Switch theme
Sign up to access all valuation multiples
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.
1926
4.5K+
LTM Revenue $2.6B
LTM EBITDA $964M
$12.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Recordati has a last 12-month revenue of $2.6B and a last 12-month EBITDA of $964M.
In the most recent fiscal year, Recordati achieved revenue of $2.5B and an EBITDA of $855M.
Recordati expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Recordati valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.5B | XXX | XXX | XXX |
| Gross Profit | $1.4B | $1.5B | XXX | XXX | XXX |
| Gross Margin | 62% | 61% | XXX | XXX | XXX |
| EBITDA | $761M | $855M | XXX | XXX | XXX |
| EBITDA Margin | 34% | 34% | XXX | XXX | XXX |
| Net Profit | $335M | $418M | XXX | XXX | XXX |
| Net Margin | 15% | 17% | XXX | XXX | XXX |
| Net Debt | $96.9M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Recordati's stock price is EUR 48 (or $51).
Recordati has current market cap of EUR 9.8B (or $10.5B), and EV of EUR 12.0B (or $12.9B).
See Recordati trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $12.9B | $10.5B | XXX | XXX | XXX | XXX | $3.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Recordati has market cap of $10.5B and EV of $12.9B.
Recordati's trades at 4.9x LTM EV/Revenue multiple, and 13.3x LTM EBITDA.
Analysts estimate Recordati's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Recordati and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $12.9B | XXX | XXX | XXX |
| EV/Revenue | 5.1x | XXX | XXX | XXX |
| EV/EBITDA | 15.0x | XXX | XXX | XXX |
| P/E | 23.6x | XXX | XXX | XXX |
| P/E/Growth | 1.3x | XXX | XXX | XXX |
| EV/FCF | -42.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpRecordati's NTM/LTM revenue growth is 10%
Recordati's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Recordati's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Recordati's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Recordati and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 34% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 44% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.6M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 21% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 40% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Recordati acquired XXX companies to date.
Last acquisition by Recordati was XXXXXXXX, XXXXX XXXXX XXXXXX . Recordati acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Recordati founded? | Recordati was founded in 1926. |
| Where is Recordati headquartered? | Recordati is headquartered in Italy. |
| How many employees does Recordati have? | As of today, Recordati has 4.5K+ employees. |
| Who is the CEO of Recordati? | Recordati's CEO is Mr. Robert Koremans. |
| Is Recordati publicy listed? | Yes, Recordati is a public company listed on MIL. |
| What is the stock symbol of Recordati? | Recordati trades under REC ticker. |
| When did Recordati go public? | Recordati went public in 1984. |
| Who are competitors of Recordati? | Similar companies to Recordati include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Recordati? | Recordati's current market cap is $10.5B |
| What is the current revenue of Recordati? | Recordati's last 12-month revenue is $2.6B. |
| What is the current EBITDA of Recordati? | Recordati's last 12-month EBITDA is $964M. |
| What is the current EV/Revenue multiple of Recordati? | Current revenue multiple of Recordati is 4.9x. |
| What is the current EV/EBITDA multiple of Recordati? | Current EBITDA multiple of Recordati is 13.3x. |
| What is the current revenue growth of Recordati? | Recordati revenue growth between 2023 and 2024 was 12%. |
| Is Recordati profitable? | Yes, Recordati is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
